Skip to main content
logo
Jubilant Pharmova Limited (BOM:530019)
India flag India · Delayed Price · Currency is INR
978.25
+16.25 (1.69%)
At close: Jul 27, 2026

Jubilant Pharmova Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
3,9858,394771-6104,139
Depreciation & Amortization
4,4043,0663,2793,3482,928
Other Amortization
-620540742735.2
Loss (Gain) From Sale of Assets
55-13-22733.7
Asset Writedown & Restructuring Costs
---1,450153.83
Loss (Gain) From Sale of Investments
-3117-250-1.47
Loss (Gain) on Equity Investments
35-511-12399.83
Stock-Based Compensation
11843853711.24
Other Operating Activities
2,340-2,5293,0221,1432,059
Change in Accounts Receivable
-995242494386-721.37
Change in Inventory
-449785908-647-956.47
Change in Accounts Payable
1,0995532322,1051.58
Change in Other Net Operating Assets
1,739-462897-1,301-106.61
Operating Cash Flow
12,26810,7219,7136,6078,375
Operating Cash Flow Growth
14.43%10.38%47.01%-21.11%-53.06%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-14,491-11,156-8,977-8,145-6,000
Sale of Property, Plant & Equipment
1,021509718635.18
Investment in Securities
-1659,507-21-1172,121
Other Investing Activities
1,0356,4762,8222,63240.21
Investing Cash Flow
-12,6004,877-6,079-5,444-3,804

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-225-1,943439.99
Long-Term Debt Issued
25,713491,17228,1042,032
Total Debt Issued
25,7132741,17230,0472,472
Short-Term Debt Repaid
-565--617--
Long-Term Debt Repaid
-20,841-11,602-1,371-28,431-647.85
Total Debt Repaid
-21,406-11,602-1,988-28,431-647.85
Net Debt Issued (Repaid)
4,307-11,328-8161,6161,824
Issuance of Common Stock
109---
Repurchase of Common Stock
-187-56-274-40-
Common Dividends Paid
-795-796-798-801-800.53
Other Financing Activities
-2,386-2,356-2,437-2,342-1,349
Financing Cash Flow
949-14,527-4,325-1,567-325.99

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1,171248116705572.88
Net Cash Flow
1,7881,319-5753014,819

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-2,223-435736-1,5382,376
Free Cash Flow Growth
-----81.10%
Free Cash Flow Margin
-2.69%-0.60%1.10%-2.45%3.88%
Free Cash Flow Per Share
-13.99-2.744.63-9.6614.92
Levered Free Cash Flow
-5,6832,847-3,412-1,581463.38
Unlevered Free Cash Flow
-4,3594,227-1,810-527.021,327

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
2,3832,3562,4372,3421,349
Cash Income Tax Paid
2,0942,3842,0772,0431,941
Change in Working Capital
1,3941,1182,531543-1,783